David A. Iglesias

1.4k total citations
33 papers, 656 citations indexed

About

David A. Iglesias is a scholar working on Obstetrics and Gynecology, Molecular Biology and Oncology. According to data from OpenAlex, David A. Iglesias has authored 33 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Obstetrics and Gynecology, 10 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in David A. Iglesias's work include Endometrial and Cervical Cancer Treatments (15 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Ovarian cancer diagnosis and treatment (6 papers). David A. Iglesias is often cited by papers focused on Endometrial and Cervical Cancer Treatments (15 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Ovarian cancer diagnosis and treatment (6 papers). David A. Iglesias collaborates with scholars based in United States, Belgium and Italy. David A. Iglesias's co-authors include Rosemarie Schmandt, Ngai Na Co, Karen H. Lu, Karen H. Lu, Pedro T. Ramírez, Russell R. Broaddus, Shannon N. Westin, Pamela T. Soliman, Melinda S. Yates and Joseph Celestino and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and American Journal of Obstetrics and Gynecology.

In The Last Decade

David A. Iglesias

32 papers receiving 633 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Iglesias United States 13 259 243 221 152 135 33 656
Bradford P. Whitcomb United States 12 314 1.2× 63 0.3× 134 0.6× 385 2.5× 165 1.2× 18 686
Kristin Bixel United States 16 366 1.4× 254 1.0× 155 0.7× 423 2.8× 173 1.3× 70 872
Taek Sang Lee South Korea 17 466 1.8× 119 0.5× 117 0.5× 417 2.7× 154 1.1× 53 842
Mariam AlHilli United States 15 647 2.5× 209 0.9× 100 0.5× 567 3.7× 134 1.0× 65 978
Cheng-I Liao Taiwan 10 157 0.6× 120 0.5× 73 0.3× 109 0.7× 102 0.8× 45 493
Fuat Demirkıran Türkiye 16 451 1.7× 132 0.5× 97 0.4× 436 2.9× 166 1.2× 76 775
Geoffrey Otton Australia 12 92 0.4× 114 0.5× 108 0.5× 84 0.6× 27 0.2× 20 397
Jan Hauspy Belgium 16 395 1.5× 185 0.8× 74 0.3× 209 1.4× 164 1.2× 30 710
Anna Di Pinto Italy 15 107 0.4× 134 0.6× 52 0.2× 176 1.2× 179 1.3× 35 483
Rainer Lehner Austria 15 134 0.5× 165 0.7× 258 1.2× 96 0.6× 110 0.8× 31 623

Countries citing papers authored by David A. Iglesias

Since Specialization
Citations

This map shows the geographic impact of David A. Iglesias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Iglesias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Iglesias more than expected).

Fields of papers citing papers by David A. Iglesias

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Iglesias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Iglesias. The network helps show where David A. Iglesias may publish in the future.

Co-authorship network of co-authors of David A. Iglesias

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Iglesias. A scholar is included among the top collaborators of David A. Iglesias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Iglesias. David A. Iglesias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lorusso, Domenica, Ignace Vergote, Roisin E. O’Cearbhaill, et al.. (2022). Tisotumab vedotin (TV) + pembrolizumab (pembro) in first-line (1L) recurrent or metastatic cervical cancer (r/mCC): Interim results of ENGOT Cx8/GOG 3024/innovaTV 205.. Journal of Clinical Oncology. 40(16_suppl). 5507–5507. 19 indexed citations
3.
Kurnit, Katherine C., Bryan Fellman, David A. Iglesias, et al.. (2022). Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study. Gynecologic Oncology. 167(3). 452–457. 5 indexed citations
4.
5.
6.
Soliman, Pamela T., Qian Zhang, Russell R. Broaddus, et al.. (2016). Prospective evaluation of the molecular effects of metformin on the endometrium in women with newly diagnosed endometrial cancer: A window of opportunity study. Gynecologic Oncology. 143(3). 466–471. 40 indexed citations
7.
Meyer, Larissa A., Brian M. Slomovitz, Bojana Djordjevic, et al.. (2014). The Search Continues. International Journal of Gynecological Cancer. 24(4). 713–717. 17 indexed citations
8.
Co, Ngai Na, David A. Iglesias, Joseph Celestino, et al.. (2014). Loss of LKB1 in high‐grade endometrial carcinoma: LKB1 is a novel transcriptional target of p53. Cancer. 120(22). 3457–3468. 22 indexed citations
9.
Iglesias, David A., Melinda S. Yates, Dharini van der Hoeven, et al.. (2013). Another Surprise from Metformin: Novel Mechanism of Action via K-Ras Influences Endometrial Cancer Response to Therapy. Molecular Cancer Therapeutics. 12(12). 2847–2856. 64 indexed citations
10.
Holman, Laura L., David A. Iglesias, Pamela T. Soliman, et al.. (2013). Long-term survival in advanced-stage uterine papillary serous carcinoma.. Journal of Clinical Oncology. 31(15_suppl). 5596–5596. 1 indexed citations
11.
Huang, Marilyn, David A. Iglesias, Shannon N. Westin, et al.. (2013). Pelvic exenteration: Impact of age on surgical and oncologic outcomes. Gynecologic Oncology. 132(1). 114–118. 22 indexed citations
12.
Iglesias, David A., et al.. (2013). Extensive cutaneous metastases of ovarian cancer after prolonged response to liposomal doxorubicin. PubMed. 5. 64–66. 2 indexed citations
13.
Soliman, Pamela T., David A. Iglesias, Mark F. Munsell, et al.. (2013). Successful incorporation of robotic surgery into gynecologic oncology fellowship training. Gynecologic Oncology. 131(3). 730–733. 11 indexed citations
14.
Zhang, Qian, Joseph Celestino, Rosemarie Schmandt, et al.. (2013). Chemopreventive effects of metformin on obesity-associated endometrial proliferation. American Journal of Obstetrics and Gynecology. 209(1). 24.e1–24.e12. 42 indexed citations
15.
Iglesias, David A., Shannon N. Westin, Marilyn Huang, et al.. (2012). The effect of body mass index on surgical outcomes and survival following pelvic exenteration. Gynecologic Oncology. 125(2). 336–342. 14 indexed citations
16.
Schlumbrecht, Matthew, Taren Johnston, David A. Iglesias, et al.. (2012). Sweet Response: Hyperglycemia and Hypertriglyceridemia as Biomarkers of Clinical Benefit for Everolimus in Patients with Recurrent Endometrial Cancer. Gynecologic Oncology. 125(2). S189–S189. 1 indexed citations
17.
Slomovitz, Brian M., John Galbincea, Taren Johnston, et al.. (2011). The search continues: Looking for predictive biomarkers for response mTOR inhibition in endometrial cancer.. Journal of Clinical Oncology. 29(15_suppl). 5016–5016. 8 indexed citations
18.
Iglesias, David A. & Pedro T. Ramírez. (2011). Role of Minimally Invasive Surgery in Staging of Ovarian Cancer. Current Treatment Options in Oncology. 12(3). 217–229. 29 indexed citations
19.
Iglesias, David A., et al.. (2010). The effectiveness of endometrial ablation with the Hydro ThermAblator (HTA) for abnormal uterine bleeding. American Journal of Obstetrics and Gynecology. 202(6). 622.e1–622.e6. 3 indexed citations
20.
Willig, James H., Andrew O. Westfall, David A. Iglesias, et al.. (2009). Durability of Initial Antiretroviral Therapy in a Resource-Constrained Setting and the Potential Need for Zidovudine Weight-Based Dosing. JAIDS Journal of Acquired Immune Deficiency Syndromes. 53(2). 215–221. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bradford P. Whitcomb Breakdown of academic impact, for papers by Kristin Bixel Breakdown of academic impact, for papers by Taek Sang Lee Breakdown of academic impact, for papers by Mariam AlHilli Breakdown of academic impact, for papers by Cheng-I Liao Breakdown of academic impact, for papers by Fuat Demirkıran Breakdown of academic impact, for papers by Geoffrey Otton Breakdown of academic impact, for papers by Jan Hauspy Breakdown of academic impact, for papers by Anna Di Pinto Breakdown of academic impact, for papers by Rainer Lehner
Rankless by CCL
2026